Video summary

Acid-Base Disorders | Clinical Medicine

Main summary

Key takeaways

Educational

Main ideas & lessons conveyed

  • Acid-base disorders are grouped into 4 primary types:

    • Metabolic acidosis
    • Metabolic alkalosis
    • Respiratory acidosis
    • Respiratory alkalosis

  • For each disorder, the video emphasizes a clinical way of thinking:

    1. Identify whether the problem is acidosis vs alkalosis
    2. Determine whether it’s metabolic vs respiratory (using ABG values)
    3. For metabolic disorders, determine the subtype (especially anion gap for acidosis)
    4. Match the etiology (cause) to expected complications
    5. Use targeted diagnostic tests (labs, urine studies, imaging when needed)
    6. Treat the underlying cause first, with limited adjunctive therapies depending on the situation

Methodology / step-by-step approach (Diagnostics)

1) Determine the primary acid-base disorder from an ABG

Obtain an arterial blood gas (ABG):

  • If pH < 7.35 → acidosis
    • If PaCO₂ > 45 → respiratory acidosis
    • If HCO₃⁻ is low → metabolic acidosis
      • Calculate anion gap (AG):
        • AG = Na⁺ − Cl⁻ − HCO₃⁻
        • If AG ≤ 12 → non–anion gap metabolic acidosis (NAGMA)
        • If AG > 12 → anion gap metabolic acidosis (AGMA)
      • Consider mixed disorders using Delta-Delta ratio:
        • Compare change in AG vs change in HCO₃⁻
        • Interpretation:
          • < 0.4 → pure NAGMA
          • 0.4 to 1 → mixed AGMA + NAGMA
          • 1 to 2 → pure AGMA
          • > 2 → AGMA + metabolic alkalosis
    • If pH > 7.45 → alkalosis
      • If HCO₃⁻ is high → metabolic alkalosis
      • If PaCO₂ is low → respiratory alkalosis

2) After identifying the primary disorder, determine the cause (workup logic)

A) Respiratory acidosis/alkalosis: use history + exam + targeted testing

Respiratory acidosis (hypoventilation → CO₂ retention):

  • Suspect cause based on clinical picture:
    • Altered mental status + opioid-like presentation
      • Improves with naloxone → opioid-induced respiratory depression
    • Benzodiazepine-like sedation
      • Improves with flumazenil → benzodiazepine-related respiratory depression
    • If no improvement with either antidote, consider brainstem pathology/stroke
  • Wheezing suggests COPD/asthma exacerbation
    • Trial bronchodilators + steroids
  • If those are ruled out, consider neuromuscular disease

Respiratory alkalosis:

  • Suspect respiratory center hyperactivity (hyperventilation)
  • Treat the underlying trigger (e.g., pain/anxiety, hypoxemia, pulmonary disease, altitude)
  • Context-specific examples highlighted:
    • Pain/anxiety → increased respiratory drive; improves with analgesia/anxiolysis
    • Hypoxemia (pneumonia/ARDS/PE/high altitude) → treat oxygen/underlying lung issue
    • Aspirin toxicity can produce metabolic acidosis + respiratory alkalosis (rare but testable)

B) Metabolic acidosis: split AGMA vs NAGMA, then narrow via specific tests

AGMA (AG > 12): narrow to 4 high-yield categories

  • DKA / ketoacidosis
  • Uremic acidosis (AKI/CKD)
  • Lactic acidosis
  • Toxic alcohol ingestion

Suggested lab strategy:

  • Check ketones + BMP/renal function
  • Check lactate
  • Check osmolar gap

Cause matching:

  • High ketones + high glucose + diabetic context → DKA
  • High creatinine/low GFR → uremic acidosis
  • High lactate → lactic acidosis, then subtype:
    • Shock/hypoperfusion → “Type A”
    • Uncoupling / impaired electron transport despite oxygen → “Type B”
      • Examples mentioned: metformin, isoniazid, thiamine deficiency, aspirin toxicity
  • Elevated osmolar gap (>10 as described) → toxic alcohols:
    • Methanol or ethylene glycol

NAGMA (AG ≤ 12): use urine studies to differentiate renal vs GI loss

  • Key test: urine anion gap (UAG)
    • Concept: ammonium chloride excretion
    • UAG positive → kidney issue (CKD or RTA variants)
    • UAG negative → GI bicarbonate loss (e.g., diarrhea) or similar

If UAG positive (renal causes): differentiate CKD vs RTAs

  • Use:
    • GFR
    • Serum potassium
    • Urine pH
  • Video’s differentiators:
    • Low GFR → CKD
    • Normal GFR + low K⁺ + urine pH > 5.5 → RTA type 1
    • Normal GFR + high K⁺ + urine pH < 5.5 → RTA type 4
    • If urine anion gap negative, consider GI causes, with one renal exception:
      • RTA type 2 can be confused with GI loss patterns

RTA vs GI clues (RTA type 2 highlighted)

  • If:
    • No diarrhea/abdominal surgery suggests GI cause,
    • Normal GFR,
    • Low K⁺,
    • Urine pH < 5.5
  • → consistent with RTA type 2

Key pathophysiology concepts & clinical complications

Metabolic acidosis (core link: low HCO₃⁻ → low pH)

  • Regardless of AGMA vs NAGMA: HCO₃⁻ drops → pH drops

Clinical complications emphasized:

  1. Hyperkalemia
    • Proton-cell shifting mechanisms tend to raise K⁺
    • Complications mentioned:
      • muscle weakness
      • EKG changes risk:
        • peaked T waves
        • PR changes
        • p-wave flattening
        • QRS widening
        • possible sine-wave patterns → VT/VF
  2. Compensatory hyperventilation
    • Driven by peripheral chemoreceptor stimulation
  3. Direct cardiac depression at very low pH
    • Reduced myocardial contractility → reduced cardiac output → hypotension
    • Emphasis: myocardial inhibition becomes likely around pH < 7.15

AGMA: what raises the anion gap?

  • Organic acids increase due to:
    • DKA (ketones: β-hydroxybutyrate, acetoacetate)
    • Uremic acidosis
    • Lactic acidosis
    • Toxic alcohols (methanol/ethylene glycol; also affects osmolar gap)

NAGMA: what lowers bicarbonate without raising the AG?

  • Typically framed as bicarbonate loss:
    • renal loss (e.g., CKD, RTA)
    • GI loss (e.g., diarrhea, pancreatic fistula)
  • Result: HCO₃⁻ decreases → pH decreases

Renal Tubular Acidosis (RTA) overview (subtypes)

The video emphasizes distal vs proximal function and urine pH/K⁺ patterns.

  • RTA type 1 (distal tubule problem)

    • Distal tubule can’t excrete protons
    • Serum HCO₃⁻ decreases → metabolic acidosis
    • Low serum K⁺ may be present
    • Urine pH > 5.5
    • Associated causes mentioned:
      • lithium
      • autoimmune disease (e.g., SLE, RA)

  • RTA type 2 (proximal tubule problem)

    • Can’t reabsorb bicarbonate effectively
    • Urine becomes acidic later after threshold issues
    • Differentiation emphasized by urine pH/K⁺ patterns
    • Associated causes mentioned:
      • multiple myeloma
      • antiseizure drugs
      • Fanconi syndrome
      • acetazolamide (pharmacologic association)

  • RTA type 4 (aldosterone-regulated distal dysfunction)

    • Low aldosterone
    • Leads to:
      • impaired proton secretion → metabolic acidosis
      • impaired K⁺ secretion → high K⁺ (hyperkalemia)
    • Urine is appropriately acidified: urine pH < 5.5

Metabolic alkalosis (core link: increased bicarbonate/free alkali → high pH)

  • Mechanism: increased HCO₃⁻ / reduced available protons

Sources highlighted as drivers:

  • Renal loss of protons (often: diuretics or hyperaldosteronism)
  • GI loss of protons + chloride (vomiting, NG suction)

Complications emphasized:

  1. Hypokalemia
    • Higher pH → less H⁺/K⁺ exchange → K⁺ shifts into cells → K⁺ falls
    • Risk: arrhythmias, including torsades de pointes risk
    • ECG patterns mentioned: T-wave changes, U waves, QT prolongation
  2. Hypoventilation (rare)
    • Low protons blunt chemoreceptor signaling → reduced respiratory drive → can lead to rising CO₂
  3. Tetany risk via low free calcium
    • Less H⁺ → more albumin binding → ↓ free Ca²⁺
    • Possible signs:
      • perioral paresthesias
      • carpopedal spasm
      • Trousseau sign
      • Chvostek sign

Treatments (treatment principles stated in the video)

General principle

  • Treat the underlying cause first.
  • Use pH/AG trends to monitor response when relevant.

Metabolic acidosis treatment (examples emphasized)

  • DKA / ketoacidosis (AGMA):

    • Insulin to drive glucose into cells and stop ketone production
    • Monitor: anion gap normalizes with improvement

  • Lactic acidosis:

    • Treat the cause to reduce lactate formation:
      • Hypovolemia → fluids; improve perfusion/oxygen delivery
      • Distributive shock → vasopressors
      • Cardiogenic shock → inotropes

  • Uremic acidosis:

    • Sodium bicarbonate may be used
    • If severe/refractory → dialysis

  • Toxic alcohol ingestion:

    • Fomepizole to block alcohol dehydrogenase and reduce toxic metabolites
    • If severe/persistent → dialysis

  • NAGMA (includes CKD/RTA/diarrhea-pancreatic fistula scenarios):

    • Sodium bicarbonate can help mainly in selected cases
    • Emphasis: it’s not equally useful for all subtypes (less helpful in RTA4 as framed)

Metabolic alkalosis treatment

  • Depends on volume status:

    • Hypovolemic alkalosis
      • Normal saline (0.9% NaCl) to restore volume + chloride
    • Hypervolemic alkalosis (hyperaldosteronism/CHF context)
      • Acetazolamide to promote bicarbonate loss and reduce alkalosis
      • KCl supplementation as diuresis often causes potassium loss while alkalosis persists

  • Common drivers framed as:

    • diuretics
    • vomiting / NG suction

Respiratory disorders treatment (examples emphasized)

  • Respiratory acidosis due to hypoventilation

    • Treat cause:
      • Opioid overdose → naloxone
      • Benzodiazepine overdose → flumazenil
      • COPD/asthma exacerbation → bronchodilators + steroids; BiPAP

  • Respiratory alkalosis

    • Treat trigger (pain/anxiety, hypoxemia/lung pathology, altitude, aspirin toxicity considerations)

Speakers / sources featured

  • Speaker: “Zack” (referred to repeatedly)
  • Video title/source: “Acid-Base Disorders | Clinical Medicine” (YouTube video)
  • No additional explicitly credited organizations/authors are identified in the subtitles.

Original video